Zobrazeno 1 - 10
of 86
pro vyhledávání: '"William H. Bisson"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/0da2a6bbb9a141999eddea2b1fe8d345
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The complexity of cancer requires a comprehensive approach to understand its diverse manifestations and underlying mechanisms. Initially outlined by Hanahan and Weinberg in 2000 and updated in 2010, the hallmarks of cancer provide a conceptual basis
Externí odkaz:
https://doaj.org/article/0f5b618b396741ca8f63a1536ae70157
Autor:
Luca Mologni, Sébastien Tardy, Alfonso Zambon, Alexandre Orsato, Cédric Schneider, William H. Bisson, Monica Ceccon, Michela Viltadi, David Goyard, Pierre Garcia, Joseph D’Attoma, Sara Pannilunghi, Vito Vece, Jerome Bertho, David Gueyrard, Peter Goekjian, Leonardo Scapozza, Carlo Gambacorti-Passerini
Publikováno v:
ACS Omega, Vol 7, Iss 25, Pp 22059-22060 (2022)
Externí odkaz:
https://doaj.org/article/06412c463a324452867b30b2e8ae1c45
Autor:
Lei G. Wang, Antonio R. Montaño, Jason R. Combs, Nathan P. McMahon, Allison Solanki, Michelle M. Gomes, Kai Tao, William H. Bisson, Dani A. Szafran, Kimberley S. Samkoe, Kenneth M. Tichauer, Summer L. Gibbs
Publikováno v:
Nature Chemistry. 15:729-739
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57f501ad9a14b3b3c289c415a284a8f1
https://doi.org/10.1038/s41557-023-01173-6
https://doi.org/10.1038/s41557-023-01173-6
Autor:
Luai R. Zarour, Sudarshan Anand, Kevin G. Billingsley, William H. Bisson, Andrea Cercek, Michael F. Clarke, Lisa M. Coussens, Charles E. Gast, Cristina B. Geltzeiler, Lissi Hansen, Katherine A. Kelley, Charles D. Lopez, Shushan R. Rana, Rebecca Ruhl, V. Liana Tsikitis, Gina M. Vaccaro, Melissa H. Wong, Skye C. Mayo
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 3, Iss 2, Pp 163-173 (2017)
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key goals for improving outcomes including early detection, effective prognostic indicators of treatment response, and accurate identification of patients at
Externí odkaz:
https://doaj.org/article/a2fb9ed7dbcc4a7e9cfe57e90dde9948
Autor:
Arden Perkins, Jessica L. Phillips, Nancy I. Kerkvliet, Robert L. Tanguay, Gary H. Perdew, Siva K. Kolluri, William H. Bisson
Publikováno v:
Biology, Vol 3, Iss 4, Pp 645-669 (2014)
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates the expression of a diverse group of genes. Exogenous AHR ligands include the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is
Externí odkaz:
https://doaj.org/article/f54bb2bd91a74ae7a99b7977add02010
Autor:
Lei G. Wang, Antonio R. Montaño, Jason R. Combs, Nathan P. McMahon, Allison Solanki, Michelle M. Gomes, Kai Tao, William H. Bisson, Dani A. Szafran, Kimberley S. Samkoe, Kenneth M. Tichauer, Summer L. Gibbs
Publikováno v:
Nature Chemistry. 15:740-740
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5def2caf307f694841d5ac2e9bf68179
https://doi.org/10.1038/s41557-023-01213-1
https://doi.org/10.1038/s41557-023-01213-1
Autor:
Luca Mologni, Sébastien Tardy, Alfonso Zambon, Alexandre Orsato, William H. Bisson, Monica Ceccon, Michela Viltadi, Joseph D’Attoma, Sara Pannilunghi, Vito Vece, Jerome Bertho, Peter Goekjian, Leonardo Scapozza, Carlo Gambacorti-Passerini
Publikováno v:
ACS omega. 7(20)
The anaplastic lymphoma kinase (ALK) is abnormally expressed and hyperactivated in a number of tumors and represents an ideal therapeutic target. Despite excellent clinical responses to ALK inhibition, drug resistance still represents an issue and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a7b1e41703657ff1df592093720c15
https://pubmed.ncbi.nlm.nih.gov/35785321
https://pubmed.ncbi.nlm.nih.gov/35785321
Autor:
Luca Mologni, Alexandre Orsato, Alfonso Zambon, Sébastien Tardy, William H. Bisson, Cedric Schneider, Monica Ceccon, Michela Viltadi, Joseph D'Attoma, Sara Pannilunghi, Vito Vece, David Gueyrard, Jerome Bertho, Leonardo Scapozza, Peter Goekjian, Carlo Gambacorti-Passerini
The Anaplastic Lymphoma Kinase (ALK) is a therapeutic target for personalized medicine in selected cancers. Despite excellent clinical responses to ALK inhibitors, most patients develop drug resistance and relapse. New compounds with alternative bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf89bd1c05f951a54aeeb8be0996d559
https://hdl.handle.net/11380/1278237
https://hdl.handle.net/11380/1278237
Autor:
Hyo Sang Jang, Martin Pearce, Edmond F. O’Donnell, Bach Duc Nguyen, Lisa Truong, Monica J. Mueller, William H. Bisson, Nancy I. Kerkvliet, Robert L. Tanguay, Siva Kumar Kolluri
Publikováno v:
Biology, Vol 6, Iss 4, p 41 (2017)
We previously reported that raloxifene, an estrogen receptor modulator, is also a ligand for the aryl hydrocarbon receptor (AhR). Raloxifene induces apoptosis in estrogen receptor-negative human cancer cells through the AhR. We performed structure–
Externí odkaz:
https://doaj.org/article/44116b87b9764194819540210e933587